Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial - The Lancet report in The Lancet Regional Health Western Pacific on the impact on skin infections of an oral ivermectin MDA targeting scabies in Fiji
This open-label, cluster-randomised study was done in 24 villages in a district endemic for lymphatic filariasis in Papua New Guinea
The Lancet; The Lancet Child & Adolescent Health; The Lancet Diabetes & Endocrinology; The Lancet Digital Health; The Lancet Gastroenterology & Hepatology; Drugs like hydroxychloroquine, ivermectin, and nitazoxanide have been prescribed for Covid-19 in Brazil (even to unconfirmed cases) often by means of the so-called “Covid
In the first big research scandal of the COVID-19 era, The Lancet and The New England Journal of Medicine ( NEJM) today retracted two high-profile papers after a company declined to make the underlying data for both available for an independent audit, following questions being raised about the research
The effect of ivermectin was greatest in the setting with the shortest transmission season, with a predicted reduction in clinical incidence of 62% for 1 × 400 μg/kg ivermectin and 71% for 3 × 300 μg/kg ivermectin
given that ivermectin is broadly considered to be the preferred drug used to treat this parasite
Although no specific cause of death is given, they suggest that the apparent excess of mortality could be due
This old, so-called wonder drug—an endectocide that targets both endoparasites and ectoparasites—was originally identified as a natural substance by Satoshi Ōmura of